• Omata D, Kawahara E, Munakata L, Tanaka H, Akita H, Yoshioka Y, Suzuki R. 

Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles. Mol Pharm. 21(11):5672-5680 (2024)

​

• Kawai A, Noda M, Hirata H, Munakata L, Matsuda T, Omata D, Takemura N, Onoe S, Hirose M, Kato T, Saitoh T, Hirai T, Suzuki R, Yoshioka Y. 

Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen. ACS Nano. 18(26):16589-16609 (2024)

​

• Hirakata M, Tomikawa E, Sakai C, Uchida M, Okano T, Shimozono R, Kawai M, Itaba S, Munakata L, Suzuki R, Oshida K.

TXB-001, a newly-developed polymer-conjugated anthracycline: Significantly lower adverse effects in animal models of alopecia and hand-foot syndrome. Toxicol Appl Pharmacol. 485: 116912 (2024)

​​